Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity

Steffi Daniel1, Marian Renwick1, Viet Q Chau1

  • 1Department of Ophthalmology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, USA.

Journal of Molecular Medicine (Berlin, Germany)
|September 23, 2020
PubMed

Insights

Fibulin-3 (F3) is crucial for corneal integrity but not essential for retinal or RPE function. Its absence in mice and humans shows potential for safe therapeutic strategies targeting eye diseases like AMD.

Area of Science:

  • Ophthalmology
  • Extracellular Matrix Biology
  • Genetics

Background:

  • Fibulin-3 (F3) is an extracellular matrix glycoprotein implicated in eye diseases.
  • A mutation in F3 causes macular dystrophy, and its absence protects mice from sub-retinal pigment epithelium (RPE) deposits.
  • The precise role of wild-type (WT) F3 in ocular tissues remains largely unknown.

Purpose of the Study:

  • To investigate the tissue-specific expression and function of Fibulin-3 (F3) within the eye.
  • To characterize the structural and functional consequences of F3 absence in ocular tissues.
  • To evaluate the potential of F3 as a therapeutic target for retinal diseases.

Main Methods:

  • Analysis of F3 expression across various mouse ocular tissues.
  • Structural and functional evaluation of ocular tissues in WT and F3 knockout (F3-/-) mice.
  • Utilized SD-OCT, histology, electron microscopy, electroretinogram, and optokinetic response tests.

Main Results:

  • F3 knockout mice exhibit progressive corneal thinning, opacity, and vascularization with age.
  • No significant structural or functional abnormalities were observed in the trabecular meshwork, neural retina, RPE, or optic nerve of F3-/- mice.
  • Absence of F3 in a human patient with loss-of-function mutations showed no retinal abnormalities.

Conclusions:

  • Fibulin-3 is essential for maintaining corneal structural integrity.
  • The absence of F3 does not compromise the structure or function of other ocular tissues, including the retina and RPE.
  • Targeted F3 inhibition presents a potentially safe therapeutic strategy for reducing sub-RPE deposits in diseases like age-related macular degeneration (AMD).

Related Concept Videos